The FDA has been approving expensive drugs at record speed even though there may be limited evidence of their effectiveness. Examples include Nuplazid (hallucinations and delusions associated with Parkinson’s disease), Uloric (gout), and Folotyn (peripheral T-cell lymphoma). Learn more about this potential quality issue. Could one of these drugs be the next thalidomide?